First Manhattan’s ChemoCentryx, Inc. CCXI Stock Holding History

First Manhattan’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-600	Closed	-$30K	–	1833
2022 Q3	$30K	Hold	600	–	–	﹤0.01%	1023
2022 Q2	$14K	Hold	600	–	–	﹤0.01%	1187
2022 Q1	$15K	Hold	600	–	–	﹤0.01%	1221
2021 Q4	$21K	Hold	600	–	–	﹤0.01%	1163
2021 Q3	$10K	Buy	600 +300	+100%	+$4.67K	﹤0.01%	1289
2021 Q2	$4K	Hold	300	–	–	﹤0.01%	1462
2021 Q1	$15K	Hold	300	–	–	﹤0.01%	1182
2020 Q4	$18K	Hold	300	–	–	﹤0.01%	1078
2020 Q3	$16K	Hold	300	–	–	﹤0.01%	1066
2020 Q2	$17K	Hold	300	–	–	﹤0.01%	1071
2020 Q1	$12K	Hold	300	–	–	﹤0.01%	1112
2019 Q4	$11K	Buy	+300	New	+$5.27K	﹤0.01%	1132
2015 Q2	–	Sell	-260,500	Closed	-$1.97M	–	1512
2015 Q1	$1.97M	Hold	260,500	–	–	0.01%	348
2014 Q4	$1.78M	Buy	+260,500	New	+$1.38M	0.01%	359

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Manhattan's CCXI Position: Q4 2022 in Review

First Manhattan sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 600 shares — an estimated $30K sold.

First Manhattan first reported a position in CCXI in Q4 2014 and held it in 14 quarters. The position peaked at $1.97M in Q1 2015. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

First Manhattan reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
First Manhattan sold 600 ChemoCentryx, Inc. shares in Q4 2022, an estimated $30K.
First Manhattan first reported a position in ChemoCentryx, Inc. in Q4 2014 and held it in 14 quarters.
First Manhattan's ChemoCentryx, Inc. position peaked at $1.97M in Q1 2015.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.